文献速递医院感染防控细菌感染、耐药与抗菌药物

神经外科术后脑膜炎的管理:叙述性综述

Management of post-neurosurgical meningitis: narrative review.
PubMed 文献 · Clin Microbiol Infect · 2017-05-18

本文为叙述性综述,总结神经外科术后脑膜炎(PNM)的流行病学、诊断与治疗。PNM 病原分布差异大,预防性抗生素及涂层装置使用后革兰阴性菌增多;脑脊液葡萄糖、乳酸和革兰染色对诊断关键,白细胞计数不特异。脑室内/鞘内抗生素及碳青霉烯联合多黏菌素对碳青霉烯耐药革兰阴性菌 PNM 可能有获益,但多数管理问题缺乏高质量证据。

要点

  • PNM 病原分布因预防性抗生素使用而向革兰阴性菌偏移。
  • 脑脊液葡萄糖、乳酸和革兰染色是诊断关键,白细胞计数不特异。
  • 碳青霉烯耐药革兰阴性菌 PNM 可考虑碳青霉烯联合多黏菌素。

核心结论

  • PNM 管理多项核心问题缺乏高质量证据,需多中心协作与独特研究设计。

研究设计与样本

  • 叙述性综述,检索 PubMed、已识别研究与综述的参考文献,证据缺乏时结合个人经验。

主要发现

  • PNM 发病率与病原分布高度可变,使用主要针对革兰阳性菌的抗生素预防及涂层装置后观察到向革兰阴性菌偏移。
  • PNM 症状较社区获得性脑膜炎更不特异,患者基线病情重,许多神经外科情况可模拟脑膜炎并导致脑脊液异常。
  • 脑脊液葡萄糖、脑脊液乳酸和革兰染色是诊断 PNM 的关键发现,脑脊液白细胞计数不特异。
  • 当前诊断能力使不可忽视比例的患者为微生物学阴性、诊断不确定的 PNM。
  • 部分数据提示脑室内/鞘内抗生素治疗可能有获益,主要针对碳青霉烯耐药革兰阴性菌所致 PNM。

关键数值与推荐

  • 对碳青霉烯耐药革兰阴性菌所致 PNM,当碳青霉烯 MIC ≤8 mg/L 时建议碳青霉烯-多黏菌素联合治疗。

临床怎么用

  • 治疗 PNM 需了解当地流行病学。
  • 诊断 PNM 应重视脑脊液葡萄糖、乳酸和革兰染色,不宜仅凭白细胞计数。
  • 对碳青霉烯耐药革兰阴性菌 PNM 可考虑脑室内/鞘内抗生素及碳青霉烯-多黏菌素联合。

局限性

  • 脑室内/鞘内抗生素有效性、耐药革兰阴性菌双药治疗有效性、常规治疗药物监测的临床获益及分流管更换最安全时机均缺乏高质量证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infections complicating neurosurgery pose unacceptable mortality and morbidity. AIMS: To summarize what is known about the epidemiology, diagnosis and treatment of post-neurosurgical meningitis (PNM). SOURCES: PubMed, references of identified studies and reviews, and personal experience when evidence was lacking. CONTENT: The incidence and pathogen distribution of PNM is highly variable. A shift towards Gram-negative bacteria has been observed with use of antibiotic prophylaxis and antibiotic-coated devices directed mainly against Gram-positive bacteria. However, knowledge of the local epidemiology is necessary to treat PNM. The diagnosis of PNM is difficult because, unlike community-acquired meningitis, symptoms are less specific; patients are ill at baseline and many neurosurgical conditions mimic meningitis and cause cerebrospinal fluid (CSF) abnormalities. Pivotal CSF findings for diagnosis of PNM are the CSF glucose, CSF lactate and Gram stain. CSF leucocyte counts are not specific in PNM. Current diagnostic capabilities leave a non-negligible category of patients with microbiologically negative, uncertain diagnosis of PNM. There is no high-quality evidence on several cardinal issues in PNM management, including the effectiveness of intraventricular or intrathecal (IV/IT) antibiotics, effectiveness of dual antibiotic therapy for multidrug-resistant Gram-negative bacteria; clinical benefit of routine therapeutic drug monitoring; and safest timing of shunt replacement. Some data point to a potential benefit of IV/IT antibiotic treatment, mainly for PNM caused by carbapenem-resistant Gram-negative bacteria. Carbapenem-colistin combination therapy is suggested for PNM caused by carbapenem-resistant Gram-negative bacteria with a carbapenem MIC ≤8 mg/L. IMPLICATIONS: Guiding the optimal management of PNM will necessitate collaborative multicentre efforts and unique study designs.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Hussein K, Bitterman R, Shofty B, et al. Management of post-neurosurgical meningitis: narrative review. Clin Microbiol Infect. 2017. PMID: 28529027. doi:10.1016/j.cmi.2017.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。